Company Filing History:
1 out of 14 
1 out of 378 
Years Active: 2011
Title: Beatrice Felber: Innovating Pharmacological Advances
Introduction: Beatrice Felber, based in Eching, Germany, is an accomplished inventor with a significant contribution to the field of pharmaceuticals. Her innovation, centered around 4,6-disubstituted aminopyrimidine derivatives, presents valuable therapeutic options for various medical conditions. With one patent to her name, Felber has laid the groundwork for advancements in treating infectious and other serious diseases.
Latest Patents: Felber's patent, titled "Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases," addresses the need for effective pharmacological agents. The invention encompasses the use of these derivatives as agents for the prophylaxis and treatment of infectious diseases, autoimmune disorders, cardiovascular conditions, and more. Moreover, the patent highlights their role as inhibitors for protein kinases, opening new avenues for research and application in the pharmaceutical industry.
Career Highlights: Throughout her career, Beatrice Felber has been associated with esteemed organizations such as Lead Discovery Center GmbH and Bayer Pharma Aktiengesellschaft. Her work has made a notable impact on the development of new therapeutic strategies and pharmaceuticals, showcasing her expertise and dedication to innovation.
Collaborations: In her journey, Felber has collaborated with notable peers, including Axel Choidas and Alexander Backes. These collaborations reflect a shared commitment to advancing scientific knowledge and creating innovative solutions in the healthcare sector.
Conclusion: Beatrice Felber exemplifies the spirit of innovation within the pharmaceutical industry. Her patented work on 4,6-disubstituted aminopyrimidine derivatives showcases her significant contribution to medical science and offers promising solutions for addressing critical health challenges. With her expertise and collaborative efforts, Felber continues to inspire future advancements in the field of pharmaceuticals.